Atlas Trials

DDI Study With Multiple-dose LX4211 and Single Dose Digoxin

Clinical trial NCT02300350 · COMPLETED

Trial details

NCT number
NCT02300350
Sponsor
Lexicon Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2014-10-01
Primary completion
2014-12-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.